Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

372 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Inflammation and Venous Thromboembolism in Hospitalized Patients with COVID-19.
Liontos A, Biros D, Matzaras R, Tsarapatsani KH, Kolios NG, Zarachi A, Tatsis K, Pappa C, Nasiou M, Pargana E, Tsiakas I, Lymperatou D, Filippas-Ntekouan S, Athanasiou L, Samanidou V, Konstantopoulou R, Vagias I, Panteli A, Milionis H, Christaki E. Liontos A, et al. Among authors: milionis h. Diagnostics (Basel). 2023 Nov 19;13(22):3477. doi: 10.3390/diagnostics13223477. Diagnostics (Basel). 2023. PMID: 37998613 Free PMC article.
Association of left ventricular diastolic dysfunction with inflammatory activity, renal dysfunction, and liver-related mortality in patients with cirrhosis and ascites.
Kalambokis G, Christaki M, Tsiakas I, Despotis G, Lakkas L, Tsiouris S, Xourgia X, Markopoulos GS, Dova L, Milionis H. Kalambokis G, et al. Among authors: milionis h. Eur J Gastroenterol Hepatol. 2024 Jun 1;36(6):775-783. doi: 10.1097/MEG.0000000000002762. Epub 2024 Mar 19. Eur J Gastroenterol Hepatol. 2024. PMID: 38526935
Clarithromycin for early anti-inflammatory responses in community-acquired pneumonia in Greece (ACCESS): a randomised, double-blind, placebo-controlled trial.
Giamarellos-Bourboulis EJ, Siampanos A, Bolanou A, Doulou S, Kakavoulis N, Tsiakos K, Katopodis S, Schinas G, Skorda L, Alexiou Z, Armenis K, Katsaounou P, Chrysos G, Masgala A, Poulakou G, Antonakos N, Safarika A, Kyprianou M, Dakou K, Gerakari S, Papanikolaou IC, Milionis H, Marangos M, Dalekos GN, Tzavara V, Akinosoglou K, Hatziaggelaki E, Sympardi S, Kontopoulou T, Mouktaroudi M, Papadopoulos A, Niederman MS. Giamarellos-Bourboulis EJ, et al. Among authors: milionis h. Lancet Respir Med. 2024 Apr;12(4):294-304. doi: 10.1016/S2213-2600(23)00412-5. Epub 2024 Jan 3. Lancet Respir Med. 2024. PMID: 38184008 Clinical Trial.
Anakinra efficacy in COVID-19 pneumonia guided by soluble urokinase plasminogen activator receptor: Association with the inflammatory burden of the host.
Kyriazopoulou E, Akinosoglou K, Florou E, Kouriannidi E, Bogosian A, Tsachouridou O, Syrigos KN, Gatselis N, Milionis H, Papanikolaou IC, Sympardi S, Dafni M, Alevizou A, Amvrazi AV, Alexandrou E, Archontoulis K, Argyraki K, Alexiou Z, Georgiou Y, Gkogka D, Kyrailidi F, Kalyva V, Nikolopoulou T, Ioannou S, Bakakos P, Karathanassiou G, Koklanos K, Miletis DN, Tili AM, Vakkas L, Vila I, Panagopoulos P, Samarkos M, Chrysos G, Dalekos GN, Poulakou G, Metallidis S, Giamarellos-Bourboulis EJ. Kyriazopoulou E, et al. Among authors: milionis h. Int J Antimicrob Agents. 2025 Jan;65(1):107405. doi: 10.1016/j.ijantimicag.2024.107405. Epub 2024 Dec 6. Int J Antimicrob Agents. 2025. PMID: 39647797 Free article. Clinical Trial.
Clarithromycin for improved clinical outcomes in community-acquired pneumonia: A subgroup analysis of the ACCESS trial.
Akinosoglou K, Leventogiannis K, Tasouli E, Kakavoulis N, Niotis G, Doulou S, Skorda L, Iliopoulou K, Papailiou A, Katsaounou P, Rapti V, Chrysos G, Seferlis T, Gerakari S, Dakou K, Papanikolaou IC, Milionis H, Kewitz S, Georgiadou S, Kontopoulou T, Tzavara V, Torres A, Niederman MS, Giamarellos-Bourboulis EJ. Akinosoglou K, et al. Among authors: milionis h. Int J Antimicrob Agents. 2024 Dec 6;65(2):107406. doi: 10.1016/j.ijantimicag.2024.107406. Online ahead of print. Int J Antimicrob Agents. 2024. PMID: 39647798 Free article.
Long-term cardiovascular safety of inclisiran: a pooled analysis of phase 3 randomized trials.
Karakasis P, Patoulias D, Barkas F, Theofilis P, Milionis H, Doumas M, Kassimis G, Tsioufis K, Fragakis N. Karakasis P, et al. Among authors: milionis h. Hellenic J Cardiol. 2024 Jun 20:S1109-9666(24)00129-5. doi: 10.1016/j.hjc.2024.06.005. Online ahead of print. Hellenic J Cardiol. 2024. PMID: 38908750 Free article. No abstract available.
372 results